NBTX
NanobiotixFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
NBTX vs peer average
25/100
NBTX vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
NVS is the first available peer comparator.
Major global pharma with oncology franchises — useful for framing potential commercial execution scenarios.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NBTX
Nanobiotix
NVS
Novartis
Grade
F
B
Momentum
7
81
Value
46
62
Sentiment
22
49
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs NVS
NBTX / NVS
Grade Position
Below peers
NBTX vs. peer average (F vs. C)
25/100
Momentum
7
NVSValue
46
NVSSentiment
22
NVSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NBTX
NVS is the first peer returned for this comparison set.